Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years. (academic.oup.com)

Authors: Mayer EF … Priddy F Journal: Clinical Infectious Diseases Published: 2026-02-04 DOI: https://doi.org/10.1093/cid/ciaf292